Dr Daniel Mahony
Mahony will continue as the UK government’s Life Sciences Investment Envoy
Read MoreMahony will continue as the UK government’s Life Sciences Investment Envoy
Read MoreThe Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles
Read MoreThe census found that 56% of people visit their GP for a UTI and 27% for thrush
Read MoreThe King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
